Introduction: A Shift Toward Biologics in Veterinary Drug Discovery
The landscape of animal health is undergoing a significant transformation as biologic therapies gain momentum over traditional small-molecule drugs. In modern veterinary therapeutic protein and peptide discovery services, researchers are increasingly leveraging engineered proteins, peptides, and biologically derived molecules...
CD BioGlyco, with years of experience in glycoengineering, has solved a large number of shortcomings of the expression systems and brought customers high-quality cell lines to produce glycoproteins. Recently, the company established a glycoengineered P. pastoris expression system which overcomes the excessive glycosylation and the final glycoprotein produced has a uniform...
Transfer lipopolysaccharide activates monocytes through TLR4, which is thought to increase the risk of cardiovascular disease in HIV-infected individuals. Recently, in a study published in Communications Biology entitled "mTOR regulation of metabolic limits of LPS-induced monocyte inflammatory and procoagulant responses," scientists from the State University of New York at Upstate Medical...
Developing a new obesity drug requires multiple steps: target validation, pharmacokinetic studies, safety assessments, and more. Protheragen Obesity is a Contract Research Organization (CRO) that provides exactly these services, with a focus on the preclinical stage. The company recently announced its full range of service offerings and research products.
According to its website,...
The global escalation of metabolic disorders has transformed obesity from a secondary health concern into a primary clinical challenge, necessitating a more sophisticated approach to pharmaceutical intervention. While the ultimate goal of any therapeutic is successful human application, the high rate of attrition in clinical trials underscores the critical need for a robust preclinical...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek